ATAI Life Sciences
ATAI
ATAI
54 hedge funds and large institutions have $169M invested in ATAI Life Sciences in 2021 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
19% less capital invested
Capital invested by funds: $209M → $169M (-$39.7M)
33% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 12
89% less call options, than puts
Call options by funds: $1.33M | Put options by funds: $11.7M
Holders
54
Holding in Top 10
2
Calls
$1.33M
Puts
$11.7M
Top Buyers
| 1 | +$4.33M | |
| 2 | +$4.07M | |
| 3 | +$2.84M | |
| 4 |
MCM
McKinley Capital Management
Anchorage,
Alaska
|
+$1.64M |
| 5 |
BC
BIT Capital
Berlin,
Germany
|
+$1.53M |
Top Sellers
| 1 | -$2.77M | |
| 2 | -$2.55M | |
| 3 | -$2.5M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$1.96M |
| 5 |
NAM
Nexpoint Asset Management
Dallas,
Texas
|
-$1.67M |